Discussion
One year of treatment with Kaftrio lowered levels of certain immune cells implicated in inflammation, led to fewer pulmonary exacerbations, and reduced detection of Pseudomonas aeruginosa in people with cystic fibrosis (CF), a real-world study found. The reductions in neutrophils and monocytes — types of white blood…